Why Capricor Therapeutics (CAPR) Stock Fell 7.42% in 10 Minutes After Q3 Earnings on Nov 10, 2026
EPS of -0.73 came in below the -0.05 estimate.
- CAPR fell 7.42% in the 10 minutes after the 16:06:02 ET headline, from $8.90 to $8.24.
- MoveSurge measured two earlier Capricor Therapeutics headlines with an attributed reaction between Aug 12, 2026 and Nov 9, 2026. The largest was -25.09% in 15 minutes, on Aug 24, 2026.
- 29,369 shares changed hands in those 10 minutes.
16:06:02 ET
Reaction by asset (real prices)
| Asset | 2m before | At release | +1m | +10m | +1m % | +10m % |
|---|---|---|---|---|---|---|
| CAPR | 8.90 | 8.90 | 8.90 | 8.24 | 0.00% | -7.42% |
Capricor Therapeutics (CAPR) shares fell 7.42% in the 10 minutes after its Q3 results reached the MoveSurge news feed at 16:06:02 ET on Tuesday, November 10, 2026. EPS of -0.73 came in below the -0.05 estimate.
CAPR in the first 10 minutes
The line that crossed at 16:06:02 ET: “CAPR Q3: EPS -0.73 vs -0.05 est”
From a reference price of $8.90 just before the headline, the stock was down 7.42%, at $8.24, after 10 minutes. 29,369 shares changed hands in those 10 minutes. The headline crossed in after-hours trading, 6 minutes after the 4:00 ET close.
Capricor Therapeutics Q3 results against estimates
| Measure | Reported | Estimate | Result |
|---|---|---|---|
| EPS | -0.73 | -0.05 | Miss |
How CAPR traded after earlier earnings releases
| Report | EPS vs estimate | Revenue vs estimate | First move |
|---|---|---|---|
| Aug 13, 2026 | -0.70 vs -0.58 | — | +1.24% in 15 min |
| May 12, 2026 | -0.59 vs -0.50 | — | not measured |
Earlier CAPR headlines and the measured reaction
MoveSurge measured two earlier Capricor Therapeutics headlines with an attributed reaction between Aug 12, 2026 and Nov 9, 2026. The largest was -25.09% in 15 minutes, on Aug 24, 2026.
- Aug 24, 2026, 09:27 ET: “Capricor Therapeutics Says FDA Extends PDUFA Target Action Date for BLA for Deramiocel, Investigational Cell Therapy for Duchenne Muscular Dystrophy, from August 22 to November 22” (-25.09% in 15 minutes)
Capricor Therapeutics at a glance
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Market value | $573 million (as of Nov 10, 2026) |
Prices are closes of 1-minute bars. Each move on this page is measured from the last completed bar before its headline.
How did Capricor Therapeutics stock react to its Q3 earnings on November 10, 2026?
The stock fell 7.42% in the 10 minutes after its Q3 results crossed at 16:06:02 ET. EPS of -0.73 came in below the -0.05 estimate.
How far did CAPR move after the headline?
From $8.90 just before the headline to $8.24 10 minutes later, a -7.42% move.
Sources
-
CAPR headline and measured reaction, Nov 10, 2026
— MoveSurge
The headline as it crossed, its timestamp, and the measured price reaction reported on this page.
Never miss the next market-moving story
Follow the core market-moving feed across equities, macro, currencies and commodities. Your subscription includes price moves after the news, search, watchlists, alerts and research tools.
Go live — 7 days for $29 Watch live headlines -- free